North America Antacids Market Size, Share & Industry Trends Analysis Report By Formulation Type (Tablets, Liquids and Others), By Mechanism of Action (Non-systemic and Systemic), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

North America Antacids Market Size, Share & Industry Trends Analysis Report By Formulation Type (Tablets, Liquids and Others), By Mechanism of Action (Non-systemic and Systemic), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

The North America Antacids Market would witness market growth of 2.5% CAGR during the forecast period (2023-2029).

Antacids may be used to alleviate some of the symptoms brought on by stomach ulcers and duodenal ulcers in the gut. These may also be used when neutralizing stomach acid is beneficial in other circumstances, such as sporadic episodes of dyspepsia. It functions by counteracting the acid produced in the stomach. They do this because antacids include bases (also known as alkalis), which are the chemical opposites of acids. Neutralization refers to the reaction between a base and an acid. The stomach contents are less caustic as a result of this neutralization. This may lessen ulcer-related pain as well as the burning that comes with acid reflux.

When antacids neutralize stomach acid, gas can be produced that may result in wind (flatulence). Simethicone, an ingredient frequently found in antacid medicines, helps prevent this foaming effect. Alginates are present in a large number of popular antacids. Most alginates function by creating a gel that floats over the stomach contents. By serving as a barrier, the gel stops stomach acid from aggravating the esophagus.

The rising incidence of gastro-esophageal illnesses and the aging population are increasing the demand in the region. Due to changes in lifestyle and other factors, the majority of Americans experience gastroesophageal reflux disease (GERD). In addition, over 60 million people in North America report having heartburn every once a month, resulting in heartburn becoming a common problem. Similarly, there are millions of antacid users in Canada. Antacids are explicitly advised for usage by Canadians by Health Canada. The FDA requested that manufacturers conduct more studies and testing on each antacid pill, as well as on how much of it to use and any potential side effects. These factors collectively propel the antacid market in this region forward.

The US market dominated the North America Antacids Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $2,157.2 Million by 2029. The Canada market is poised to grow at a CAGR of 4.5% during (2023 - 2029). Additionally, The Mexico market would witness a CAGR of 4.3% during (2023 - 2029).

Based on Formulation Type, the market is segmented into Tablets, Liquids and Others. Based on Mechanism of Action, the market is segmented into Non-systemic and Systemic. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Alkem Laboratories Ltd., Bayer AG, Cipla Limited, Pfizer, Inc., Prestige Consumer Healthcare, Inc., Reckitt Benckiser Group PLC, WellSpring Pharmaceutical Corporation (Avista Capital Partners), Sanofi S.A. and Sun Pharmaceutical Industries Ltd.

Scope of the Study

Market Segments covered in the Report:

By Formulation Type

• Tablets
• Liquids
• Others

By Mechanism of Action

• Non-systemic
• Systemic

By Distribution Channel

• Drug Store & Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Country

• US
• Canada
• Mexico
• Rest of North America

Companies Profiled

• Abbott Laboratories
• Alkem Laboratories Ltd.
• Bayer AG
• Cipla Limited
• Pfizer, Inc.
• Prestige Consumer Healthcare, Inc.
• Reckitt Benckiser Group PLC
• WellSpring Pharmaceutical Corporation (Avista Capital Partners)
• Sanofi S.A.
• Sun Pharmaceutical Industries Ltd.

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free